A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
for Alzheimer Disease
52 locations incl. Phoenix
Sponsor: Eli Lilly and Company
Sex: All·Age: 55+
Code: NCT07602582·Phase 3·Recruiting·Listed May 2026
Care Access - Lima
Clinical research site in Lima, Ohio · 1005 BELLEFONTAINE AVE, SUITE 100, LIMA, OH 45804-2851 · (419) 227-5879
Part of Care Access
As of July 2026, 3 paid clinical trials are recruiting at Care Access - Lima in Lima, Ohio. Active studies at this site cover conditions such as Obesity, Overweight and Alzheimer Disease. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Care Access - Lima (3)
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
for Overweight
59 locations incl. Birmingham
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07392190·Phase 3·Recruiting·Listed Feb 2026
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
for Overweight
60 locations incl. Birmingham
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07282600·Phase 3·Recruiting·Listed Dec 2025
More research sites in Lima
- Saint Rita's Medical Center (14 trials)
- NexGen Research (6 trials)
- 89bio Clinical Study Site (1 trial)
- Clinical Trial Site (1 trial)